Passage Bio, Inc. (PASG)

4.75 -0.29 (-5.75%) USD  |  NASDAQ  |  Sep 18, 16:00
4.70 -0.05 (-1.05%) After-Hours: 20:00
More

Passage Bio Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for PASG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
June 26, 2026 --
June 10, 2026 --
May 06, 2026 --
April 24, 2026 --
April 21, 2026 --
April 20, 2026 --
April 06, 2026 --
March 31, 2026 --
March 30, 2026 --
March 04, 2026 --
March 03, 2026 --
February 10, 2026 --
December 31, 2025 --
November 24, 2025 --
November 18, 2025 --
November 12, 2025 --
November 11, 2025 --
Date Value
October 08, 2025 --
September 30, 2025 --
August 13, 2025 --
June 24, 2025 --
June 23, 2025 --
May 19, 2025 --
May 15, 2025 --
May 13, 2025 --
March 04, 2025 --
December 03, 2024 --
October 07, 2024 --
September 30, 2024 --
September 16, 2024 --
August 09, 2024 --
August 01, 2024 --
June 30, 2024 --
May 14, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
ARS Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade